SWOG clinical trial number
SWOG-8415

Evaluation of Tamoxifen in Unresectable and Refractory Meningiomas, Phase II

Closed
Phase
Published
Abbreviated Title
Evaluation of Tamoxifen in Unresectable and Refractory Meningiomas, Phase II
Activated
07/20/1984
Closed
07/01/1988

Publication Information Expand/Collapse

1993

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: A Southwest Oncology Group study.

JW Goodwin;J Crowley;HJ Eyre;B Stafford;KA Jaeckle;JJ Townsend Journal of Neuro-Oncology 15:75-77

1987

Tamoxifen in the treatment of refracatory meningiomas A SouthwestOncology Group study.

W Goodwin ASCO 6:70 (#270)